<DOC>
	<DOCNO>NCT02753140</DOCNO>
	<brief_summary>Verify effect incidence oral mucositis concurrent chemoradiotherapy locally advance squamous cell carcinoma head neck versus concomitant cetuximab radiotherapy neoadjuvant chemotherapy . The predictive effect Apurinic/apyrimidinic endonuclease 1 ( APE1 ) / Ref-1 protein Apurinic/apyrimidinic endonuclease 1 ( APE1 ) /Ref-1 antibody oral mucositis .</brief_summary>
	<brief_title>Concurrent Chemoradiotherapy ( CRT ) Locally Advanced ( LA ) SCCHN v Cetuximab With Radiotherapy ( RT ) After Neoadjuvant Chemotherapy</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cetuximab</mesh_term>
	<criteria>1 . Histologically cytologically confirm first diagnosis locally advance squamous cell carcinoma head neck 2 . Imaging ( MRI , CT , bone scan ) stage Ⅲ、Ⅳa ( T12N2M0、T3N02M0、T4N02M0 ) ( 2010AJCC stag criterion ) 3 . 18 year age old 4 . Presence least 1 measurable lesion accord RECIST version1.1 5 . DO N'T accept surgery , chemotherapy irradiation trial entry 6 . Eastern Cooperative Oncology Group ( ECOG ) 0 1 7 . Expected survival period 6months 8 . Before RT randomization , bone marrow liver kidney function patient meet follow criterion : Hemoglobin ( HB ) ≥ 100g/L , neutrophil ≥ 2.0 × 109/L platelet ≥ 100 × 109/L Total bilirubin ≤ 1.5 time upper limit normal , aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) ≤ 1.5 time upper limit normal ; More 1.5 time upper limit normal serum creatinine creatinine clearance rate ≥ 60 ml/min , urea N ≤ 200mg/L ; The blood glucose level : good blood glucose control , fast glucose , 3.97.2mmol/L postprandial blood glucose less 10.0mmol/L , HbA1c &lt; 7 % ; 9 . Signed write informed consent trailrelated activity carry . 1 . Patients accept chemotherapy、radiotherapy surgery ; 2 . Distant metastasis trail entry 3 . Female subject pregnant breast feeding ; 4. oral mucositis oral mucositis repeatedly make ( 1 time / month ) Chemotherapy radiotherapy ; 5 . With teeth periodontitis ; 6 . Any investigational medication within 30 day trial entry ; 7 . Elderly patient dry stomatitis ; 8 . Any unstable system disease : include active infection , uncontrolled hypertension , unstable angina pectoris , within last 3 month onset angina , congestive heart failure , group June myocardial infarction , need serious mental disorder drug treatment , liver , kidney metabolic disease ; mental / spiritual diseases Alzheimer 's disease ; 9 . Total bilirubin &gt; 1.5 time upper limit normal , aspartate aminotransferase ( AST ) alanine aminotransferase ( ALT ) &gt; 2.5 time upper limit normal ; 10 . On gastrointestinal physiology perfect , absorb obstacle syndrome , unable tolerate oral medication , active peptic ulcer； 11 . Past current history neoplasm oher squamous cell carcinoma head neck ; 12 . Judgment accord researcher , serious harm patient safety affect patient complete study disease , patient compliance difference ; 13. know human immunodeficiency virus ( HIV ) infection ; 14 . With immunodeficiency disease , suffer acquire , congenital immunodeficiency disease , history organ transplantation ; 15 . Any disease , metabolic disorder , physical examination laboratory suspicion treatment complication patient high risk drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
</DOC>